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Abstract
Background:  Manipulation of the follicular phase uterine epithelium in women undergoing
infertility treatment, has not generally shown differing morphological effects on uterine epithelial
characteristics using Scanning Electron Microscopy (SEM) and resultant pregnancy rates have
remained suboptimal utilising these manipulations. The present study observed manipulation of the
proliferative epithelium, with either 7 or 14 days of sequential oestrogen (E) therapy followed by
progesterone (P) and assessed the appearance of pinopods (now called uterodomes) for their
usefulness as potential implantation markers in seven women who subsequently became pregnant.
Three endometrial biopsies per patient were taken during consecutive cycles: day 19 of a natural
cycle - (group 1), days 11/12 of a second cycle after 7 days E then P - (group 2), and days 19/22 of
a third cycle after 14 days E then P - (group 3). Embryo transfer (ET) was performed in a subsequent
long treatment cycle (as per Group 3).
Results:  Seven pregnancies resulted in seven viable births including one twins and one miscarriage.
Analysis of the individual regimes showed 5 days of P treatment to have a higher correlation for
uterodomes in all 3 cycles observed individually. It was also observed that all 7 women
demonstrated the appearance of uterodomes in at least one of their cycles.
Conclusions:  We conclude that manipulation of the follicular phase by shortening the period of
E exposure to 7 days, does not compromise uterine epithelial morphology and we add weight to
the conclusion that uterodomes indicate a receptive endometrium for implantation.
Introduction
Uterodomes are apical cellular protrusions which occur
during the "nidation window" and have been used as
uterine markers in conjunction with biopsy and scanning
electron microscopy to determine the timing of implan-
tation [1,2,3,4,5,6,7,8]. In some animals true pinocytotic
structures have been demonstrated but in other animals
including humans, the function of these structures,
which somewhat resemble pinopods, is unknown. Hence
[9] has suggested that these structures be referred to as
uterodomes. Regardless of the function of uterodomes
they are, however, a useful indicator of uterine receptiv-
ity in many studies including humans.
The correlation between uterodome appearance and the
nidation window first proposed by Psychoyos [10; 11], is
now generally accepted. However there are still some
mammals including humans where the presence and
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therefore function of uterodomes is not understood. This
current work is part of ongoing worldwide interest in the
cellular plasma membrane transformation to define the
reason for the appearance of these structures [9; 12].
Typically in IVF programs for frozen-thawed embryo
transfer (ET) in women with normally functioning ova-
ries or in women receiving oocyte donation, the en-
dometrium is prepared with exogenous hormones in a
manner imitating that of the natural cycle in preparation
for ET. Although several protocols for uterine prepara-
tion employing incremental doses of E2 and P have been
suggested [13,14,15,16,17,18] observation of normal mor-
phological changes using light and electron microscopy
has demonstrated that exact hormonal mimicking of the
natural cycle is not necessary. This has meant that se-
quential 'same dose' E2 and P regimes (as compared to
incremental dose) can be implemented without the need
for variation of dose throughout the cycle
[19,20,21,22,23,24,25,26].
More recently, manipulation of the follicular phase of the
natural cycle to shorten or extend the length of the cycle
beyond its physiological limits has been investigated. In
the naturally occurring cycle, short or prolonged follicu-
lar phases are uncommon-only 7% are <11 days and 5%
are >20 days [27].  The implication of this observation is
that 'timed' donor oocyte programs can be initiated with
synchronous priming of endometrial receptivity in the
recipient.
Investigators testing the hypothesis that morphological
endometrial integrity reflected functionality ie: implan-
tation and pregnancy, concluded that there was no dif-
ference between implantation and pregnancy rates [21;
25; 28]. Moreover, it was shown that the proliferative en-
dometrium is tolerant of some degree of manipulation of
the duration of the follicular phase from as short as 5 to
as long as 100 days prior to the administration of P [15,
19, 22, 26, 29,30,31]. Other studies suggested that the re-
ceptivity of the endometrium, as assessed by pregnancy
rates, was best preserved when the follicular phase was
kept between 12 and 19 days [23, 25, 32]. Short follicular
phases (<11 days) were however, correlated with early
pregnancy loss [21, 33, 34].
In the present work, as part of an ongoing clinical study
of women in an IVF programme, 7 women were chosen
for endometrial analysis because of their resultant suc-
cessful pregnancies. These women had previously failed
to conceive, either after ovarian hyperstimulation or fro-
zen cycle embryo transfer. Part of this study included
manipulation and comparison of the secretory uterine
epithelium, by using short (7 days) and longer (14 days)
sequential doses of exogenous E2 followed by P adminis-
tration with the morphology of their normal cycle. En-
dometrial morphology with the aid of SEM was then
assessed to determine whether the presence, abundance
and developmental stage of uterodomes were useful
markers to determine optimal timing of appropriate en-
dometrial maturation which would facilitate successful
implantation and pregnancy.
Materials and methods
The women in the study group were recruited in a single
centre, were aged between 28 and 44 years (mean age
32.9 years) and had cryopreserved embryos from previ-
ous in vitro fertilization attempts. Of these 7 women who
subsequently became pregnant 4 were diagnosed with
tubal factor and one each with endometriosis, idiopathic
infertility and male factor. All women gave informed
consent and the study was assessor-blind. Each patient
received oral 50 mcg ethinyloestradiol/day ('Estigyn',
Duncan Flockhart) starting on cycle day 1 and continued
throughout the cycle. Progesterone (USP) 300 mg/day,
as vaginal pessaries, was commenced on day 8 of the
'short follicular phase' study and on day 15 of the 'longer
follicular phase' study. Blood serum levels were not fol-
lowed because it is accepted that there is little or no cor-
relation between endometrial morphology and blood
hormone levels [35,36,37].
Ovulation was calculated from LMP in the natural cycle
since the women were cycling regularly on a 28 day cycle.
Therefore it was not deemed necessary to determine ovu-
lation by LH surge. In the artificial cycles, the ovarian ac-
tivity was not suppressed by GnRH. Although some
women who are on programmed cycles may spontane-
ously ovulate, the exogenous hormones override any ef-
fects presumed from the endogenous hormones [26, 38].
Three consecutive cycles were observed in each of these
patients:
Regime 1: Natural Cycle - no exogenous E2 and P. Biop-
sies were taken on day 19, (on a 28 day natural cycle, the
secretory epithelium would be equivalent to that of 5
days of progesterone preparation).
Regime 2: Short Follicular Phase. Starting at the LMP
date, continuous E2 was administered. On D8, P was
commenced and E2 was continued as before. Biopsies
were taken on D 11 or D 12, (equivalent to 4 or 5 days of
progesterone preparation).
Regime 3: Longer Follicular Phase. As for regime 2 but P
commenced on D 15 of the cycle. Biopsies were taken on
D 19 or D 22, (equivalent to 5 or 8 days of progesterone
preparation).One patient however received her biopsy
on day 21.BMC Pregnancy and Childbirth (2001) 1:2 http://www.biomedcentral.com/1471-2393/1/2
Tissue Collection
Uterine epithelial biopsies were taken from the anterior
fundus, using a Novak curette while the patient was un-
der sedation. The tissue was immediately rinsed in phos-
phate buffer (PO4) 0.1 M pH 7.4 and placed in 2.5%
Glutaraldehyde in 0.1 M PO4 for fixation, rinsed in 0.1 M
PO4 pH 7.4 and placed in fresh 0.1 M PO4 pH 7.4.
Scanning Electron Microscopy
For scanning electron microscopy the fixed tissue was
cut into 3 mm pieces and post fixed in 2% Osmium
Tetroxide (OsO4) in 0.1 M PO4 pH 7.4 and rinsed in 0.1
M PO4 pH 7.4. Tissue was incubated in freshly prepared
1% thiosemicarbazide, rinsed in distilled water and rein-
cubated in 1% OsO4 (aqueous). After further washing in
distilled water the tissue was dehydrated through graded
ethanols to 100%, prepared for critical point drying,
mounted onto aluminium stubs, sputter coated to 20 nm
with platinum and viewed using a Philips Scanning Elec-
tron Microscope (SEM) 505 operating at 20 keV.
SEM was used to observe and date the endometrial mor-
phology The presence of uterodomes was graded as: (ab-
sent, few, moderate or abundant); and their
development as: (developing, fully developed or regress-
ing) [7, 8, 39, 40].
Results
The resultant 7 pregnancies consisted of 7 live births
(one twins) and one miscarriage. The secretory uterine
epithelial morphology of these seven women was ob-
served for uterodomes and correlated to the length of P
exposure both individually and as groups per treatment
regime.
Analysis of the individual regimes showed 5 days of P
treatment to have a higher correlation for uterodomes in
all 3 cycles observed individually. It was also observed
that all 7 women demonstrated the appearance of utero-
domes in at least one of their cycles.
Three patients biopsied on D5 of presumed P exposure in
their natural cycle did not display uterodomes and their
epithelium was found to be either (1) suboptimal or (2)
retarded (Figure 1a). The suboptimal epithelium dis-
played variable morphology of flattened, pleiomorphic
cells without cell borders, variable microvilli coverage
and structure, few cilia groups and erosion or cellular po-
rosity. The retarded epithelium - one biopsy dated as
'early proliferative', displayed ciliogenesis, pronounced
cell borders, large polyhedral cells, dense flat microvilli
and/or secretion droplets. Both hormonal regimes, ei-
ther 7 or 14 days of E before P commencement, improved
the appearance and amount of epithelia when compared
to the natural cycle with uterodomes being observed at
D5P (Figure 1b). Where uterodomes were observed 'fully
developed' at D5 on short E2 they were found to be 'de-
veloping' at D7 on long E2, suggesting their possible
maturation at D8 (Figure 1c).
Table 1 sets out the individual patient biopsy results for
each cycle. It can be seen that patients 2 and 6 benefited
from both hormone regimes when compared to their
natural cycles, as did patient 5. Patient 4 showed no dif-
ference between her natural cycle and treated cycles at
D5 and the D4 appearance of developing uterodomes
postulates that they would be fully developed by D5.
However uterodome abundance for both regimes in-
creased to 'moderate' compared to 'few' in the natural cy-
cle. Where uterodomes were 'fully developed' in the
natural cycle D5 (Figure 2a) they were not observed on
D8 in patient 1 and were 'developing' in patient 7, and
when observed in conjunction with other epithelial char-
acteristics, such as clumping of swollen microvillous tips
on protruding cells, demonstrated a retarded epithelium
suggestive of pinopod development on D9/10, that is
long E2 resulted in a shift in the nidation window (Figure
2b). Patient 3 also demonstrated a retarded epithelium
on D8 where uterodomes were not observed.
Where epithelium was well presented in the natural cy-
cle, neither of the exogenous regimes had further benefi-
cial effect. The two hormonal regimes did not show
Table 1: Stages of uterodome development (0=absent, 1=developing, 2=developed, 3=regressing) and uterodome abundance (+ = few, 
++ = moderate, +++ = abundant, N/A = no epithelium) in consecutive cycles in 7 patients who subsequently became pregnant.
Patient Biopsy I (Day 5) Biopsy 2 (Day 5) Biopsy 3 (Day 5)
1 2 +++ N/A 0(D8)
2001  +
3 N/A 1 (D4) + 0 (D8)
4 2 + 1 (D4) ++ 2 +
5 0 2 +++ 1 (D7) +++
601  + 1  + + +
7 2 + 2 +++ 1 +++BMC Pregnancy and Childbirth (2001) 1:2 http://www.biomedcentral.com/1471-2393/1/2
differential changes in the morphology of the secretory
epithelium between equivalent biopsy days but did show
a definite trend in an increase in abundance of utero-
domes regardless of their maturational stage (Figure
3a;b).
Discussion
In some animals pinopods are known to be pinocytotic
and are directly implicated in the implantation process
[41,42,43] but in the human and other animals their
function is unknown [9]. However the appearance of
these structures at, or just prior to the time of implanta-
tion suggests they may play a functional role in the hu-
man secretory epithelium and implantation [3, 12, 39,
44].
In the normal 28 day menstrual cycle, uterodomes occur
at D19-21 (5-7P) [44, 45]. However, in artificial cycles
maintained with exogenous hormones, uterodomes have
been shown to occur at D21-22 (7-8 P) suggesting that
the window of receptivity in artificially induced cycles
can be postponed [3, 39]. When sequential sampling was
performed during a single natural or artificial cycle (non
ovarian stimulated) the timing of uterodome appearance
was found to vary by up to 5 days between women [8].
This individual variability could account for observa-
tions in the present study where uterodomes were not
observed in 3 patients at D5 in the natural cycle. Other
discrepancies between the menstrual and replacement
cycles have also been shown to occur with delay in mor-
phological maturation being observed in the mid luteal
phase [13, 15, 46, 47]. The variability of response be-
tween individuals can be monitored with endometrial bi-
opsy and specifically taylored HRT for patients on an IVF
program.
The women in this study were infertile but not annovula-
tory and as such it was expected that their epithelium
would be responding to their own hormones. Although a
delayed epithelial response could be expected because of
individual variablility, an improved epithelial response
to adjunctive hormone supplementation was also ob-
served. With the advent of biopsy and SEM analysis we
are able to directly observe the morphological integrity of
the epithelium as compared to the assumed integrity de-
duced from standard hormone dose delivery, time of
ovulation and serum hormone levels. This allows the ep-
ithelial response to be 'dated' so that timing of utero-
dome appearance can be predicted. Since the women
acted as their own controls in this study, their natural
and artificial cycles were assumed to have the same
chronological sequence of endometrial development and
as such Days 8 and 15 in the programmed cycles were =
P1. In this study patients who displayed a delayed or sub-
optimal epithelium in the natural cycle did become preg-
Figure 1
Scanning electron micrographs of 3 biopsies from the same
patient (no. 5) demonstrates the variable response of the epi-
thelium to exogenous hormone supplementation. (A) subop-
timal epithelial appearance for D5 natural cycle displaying
variable morphology of flattened, pleiomorphic cells without
cell borders, variable microvilli coverage and structure and
few cilia groups. (B) D5 of the short E2 cycle shows an abun-
dance of fully developed uterodomes, (C) D7 of long E2 cycle
shows developing uterodomes. Scale bar = 10 µm.BMC Pregnancy and Childbirth (2001) 1:2 http://www.biomedcentral.com/1471-2393/1/2
nant with ET utilising the longer cycle (El4, 5P) thus
suggesting that hormone supplementation is needed to
bring the endometrial epithelium into a state of 'normal'
morphology [48]. However this does not imply that preg-
nancy might not occur with a shorter cylce. It does sug-
gest that the subsequent supplemented cycles may
standardise the epithelial response [14, 49].
It has previously been observed that while the morphol-
ogy of a normal secretory epithelium in a natural cycle
[45] is not affected by an artificial cycle in some patients
[24, 39], the integrity of the epithelium is not always pre-
served in one or other of the subsequent cycles and this
suggests an out-of-phase epithelium that is either de-
layed or advanced [50,51,52,53]. [7] states "on average,
pinopodes form earlier in stimulated cycles and later in
hormone replacement cycles, compared with natural cy-
cles", and that increasing the dose of hormones gives bet-
ter results in achieving pregnancies. Providing sufficient
E2 is given for endometrial priming [54], it is the dura-
tion of exposure to P, rather than the duration of E2
priming, that is a crucial factor in triggering endometrial
receptivity [17, 18, 24, 55].
Our results help to demonstrate that in fact, the presence
of uterodomes, and thus the 'nidation window', was de-
layed when hormone supplementation was adminis-
tered. The results also demonstrate that utilising a short
follicular phase cycle does not appear to compromise
uterodome appearance, abundance and shape, and that
hormone supplementation may produce a positive effect
on the abundance of uterodomes.
Women who demonstrated poor or suboptimal epitheli-
um in their natural cycle were observed to show an im-
provement in epithelial characteristics and appearance
of uterodomes with hormone supplementaion cycles.
Those with well developed epithelium in their natural cy-
cles did not appear to benefit morphologically from hor-
mone supplementation. If the appearance of uterodomes
does herald the window of implantation, then considera-
tion may be given to the usefulness of hormone supple-
mentation in controlling future cycles in these
individuals for timing ET. The findings of this study sup-
port the following observations that, (1) the consecutive
cycles of hormone supplementation we used, while not
identical, can delay the appearance of uterodomes, (2)
the short E2 treatment did not alter the timed epithelial
sequence apparent in an individual's natural cycle, (3)
the longer E2 treatment influenced, by retarding, the
timing of the epithelial characteristics in comparison to a
shorter E2 treatment protocol, (4) in patients showing
poor epithelial morphology in natural cycles, exogenous
E2 and P supplementation may increase the abundance
of uterodomes, which has been correlated to improved
pregnancy rates [7].
In summary, since all patients displayed uterodomes in
at least one of their cycles, it is likely that uterodome ap-
pearance at or just prior to the time of implantation may
be an indicator of the functional integrity of the en-
dometrium. While we have not demonstrated pregnancy
rates in short proliferative cycles, this study provides fur-
ther evidence that baseline biopsies and manipulation of
the secretory epithelium is a useful tool for timing suc-
cessful ET.
Figure 2
Scanning electron micrographs of the same patient (no. 1)
demonstrates a shift in the nidation window with exogenous
hormones. (A) An abundance of fully developed uterodomes
are shown on D5 of the natural cycle. (B) D8 long E2 shows
retarded epithelium suggestive of pinopod appearance 1-2
days later. Note clumping of swollen microvillous tips on
protruding cells and secretory droplets. Scale bar = 10 µm.
Figure 3
Scanning electron micrographs from the same patient (no. 7)
at D5 in different cycles demonstrated an increase in abun-
dance of uterodomes utilising exogenous hormones. Scale
bar = 10 µm. (A) Epithelium displaying few uterodomes in
the natural cycle (B) An increase in abundance of utero-
domes after hormone supplementation is observed.BMC Pregnancy and Childbirth (2001) 1:2 http://www.biomedcentral.com/1471-2393/1/2
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